Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery

Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery

- Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development - Investment highlights Samsung's dedication to advancing innovation and creating a...

Samsung Biologics listed among top most sustainable companies in Dow Jones Sustainability World Index

Samsung Biologics listed among top most sustainable companies in Dow Jones Sustainability World Index

Acknowledged for strong environmental, social, and governance (ESG) performance and continued commitment to sustainability through net-zero initiatives and responsible value chain management INCHEON, South Korea, Dec. 17, 2024 /PRNewswire/ --...

Samsung Biologics hosts ESG event with suppliers to strengthen decarbonization efforts

Samsung Biologics hosts ESG event with suppliers to strengthen decarbonization efforts

INCHEON, South Korea, Dec. 3, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today hosted its second Supplier ESG Day to share insights on sustainable management and...

menu
menu